Amphotericin B liposomal Tillomed

Medicinal product

(Invented) name

Amphotericin B liposomal Tillomed

Active substance (s)

Amfotericinas B

Strength

50 mg

Pharmaceutical form

milteliai infuzinės dispersijos koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J02AA01, Amphotericin B

Marketing authorisation holder

Tillomed Malta Limited, Malta

Date of authorisation

2025-06-03

Date of renewal

Documents

5794_pakuotes lapelis_2025-06-03.docx

5794_Amphotericin_Tillomed.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

DE/H/7886/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Amfotericinas B	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117673	103776	1103776	flakonas	N1 (+5 mikronų filtras)		Receptinis	LT/1/25/5794/001	Netiekiama	-	-	No	-	-
117674	103777	1103777	flakonas	N10 (+5 mikronų filtras)		Receptinis	LT/1/25/5794/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-06-03	Registruotas